Warring tech CEOs fight over the future of 3D printing in a thunderously loud action movie scored by Nine Inch Nails.
Canada is often celebrated for its polite culture, beautiful landscapes, and stable governance. However, beyond these ...
WELLESLEY HILLS, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...
Security Sensitive customer info exposed in Mango data breach - here's what we know Security Nearly 180k records exposed in billing platform breach - here’s what we know Security 800,000 users at risk ...
Crypto.com CEO Kris Marszalek says the exchange had disclosed a 2023 security breach to regulators, and accusations suggesting otherwise were misinformation. Crypto exchange Crypto.com has denied that ...
New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody CLYM116 Phase 1 trial initiation expected in Q4 2025, with ...
Country’s largest import terminal and busiest cruise destination has come up with a ‘spot cleaning’ biofouling solution as cruise lines balk at entering NZ waters on rigid bio-security rules. Port of ...
Suspected Chinese hackers have used the Brickstorm malware in long-term persistence espionage operations against U.S. organizations in the technology and legal sectors. Brickstorm is a Go-based ...
Stellantis, one of the world’s largest automakers, confirmed suffering a cyberattack and losing sensitive customer data. In a short announcement, Stellantis said the breach did not occur within its ...
The following statement is being issued by Kroll Settlement Administration regarding the Cencora Data Security Incident Settlement. A proposed Class Settlement arising out of a Data Security Incident ...
CONSHOHOCKEN, Pa., Sept. 19, 2025 /PRNewswire/ -- The following statement is being issued by Kroll Settlement Administration regarding the Cencora Data Security Incident Settlement. A proposed Class ...
BOSTON - Vor Bio (NASDAQ:VOR), whose stock has surged over 137% in the past year and 20% in the last week alone, announced Monday that clinical data from a Phase 3 study of telitacicept in adults with ...